glp 1 blue cross Beyond the Buzz: Understanding the GLP-1 Trend BCBSM pulling back on GLP-1

SGLT1 is primarily expressed in the epithelial lining of the intestines while SGLT2 is primarily located in the lining of the nephron in the kidneys

This quarter already saw a double-digit revenue growth in the segment as a large gene therapy product whose revenue was treated as development revenue a year ago is now treated as commercial revenue. Catalents largest gene therapy customer is Sarepta Therapeutics, which saw the US Food and Drug Administration (FDA) approve its adeno-associated virus-based gene therapy Elevidys (delandistrogene moxeparvovec) back in June

With results from six randomized controlled trials, three systematic reviews, and more than 40,000 patients, the study is the first synthesis of its kind

Yes, semaglutide is considered safe for patients with benign thyroid nodules when medullary thyroid cancer and MEN2 are ruled out by your medical history